Medicinal Chemistry Approaches for Combatting SARS-CoV-2 and COVID-19 Therapeutics

Read full text Summarise with VIRAT
Authors: Neelottama Kushwaha, Swatantra K.S. Kushwaha, Anmol Kumar
Cited by: 0
References: 1

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The COVID-19 pandemic has underscored the need for innovative and adaptable solutions in medicinal chemistry to address the growing global health challenges. New strategies, including structure-based drug design, AI-driven drug discovery, and drug repurposing, have shown promising advancements in accelerating the creation of therapeutic treatments. Significant strides have been made in focusing on crucial viral proteins, particularly the main protease (Mpro) and RNA-dependent RNA polymerase (RdRp), which have created new opportunities for small-molecule inhibitors. Additionally, advancements in peptide-based therapies, monoclonal antibodies, and nanotechnology-enhanced drug delivery systems have expanded the tools available against SARS-CoV-2. However, significant challenges persist, such as addressing viral mutations, improving access to medications, and ensuring rapid scalability of treatments. Ongoing investment in interdisciplinary collaborations, enhanced screening technologies, and real-time genetic monitoring will be essential for refining these strategies. By adopting a proactive approach, medicinal chemistry can respond to the current pandemic and lay the groundwork for effectively tackling future viral threats with greater precision and efficiency.

Fields of Study & Subjects

SARS-CoV-2 and COVID-19 Research Computational Drug Discovery Methods COVID-19 Clinical Research Studies

Publication details

Journal / source
Fabad Journal of Pharmaceutical Sciences
Volume
51
Issue
1
Pages
351–382
Publication date
31 March 2026
Language
TR